
Sulforaphane, a bioactive compound found in cruciferous vegetables such as broccoli, kale and cabbage, is gaining increasing attention from scientists due to its ability to fight cancer. This natural substance influences key biological processes associated with the development, growth and spread of tumours. Clinical evidence and new trends show that sulforaphane may play an important role not only in cancer prevention but also in its treatment.
Sulforaphane and detoxification: Protection at the cellular level
One of the main mechanisms by which sulforaphane works is its ability to activate detoxification enzymes. These enzymes act as the body’s protective system:
- Phase I: Sulforaphane regulates enzymatic processes that neutralise potential carcinogens.
- Phase II: Promotes the elimination of harmful substances by activating enzymes such as glutathione-S-transferases (GST) and NQO1.
Studies have shown that sulforaphane can reduce levels of carcinogenic metabolites in the body by up to 61% (Fahey et al., 2011). Regular consumption of broccoli sprouts therefore contributes significantly to detoxification of the body and cancer prevention.
Destruction of cancer cells: Apoptosis and inhibition of angiogenesis
Sulforaphane specifically kills cancer cells through apoptosis (programmed cell death), leaving healthy cells unharmed. It achieves this effect by inhibiting histone deacetylase (HDAC) enzymes, which suppress tumour suppressor genes.
Another important mechanism is the inhibition of angiogenesis – the process by which tumours create new blood vessels to ensure their nutrition and growth. Sulforaphane blocks the growth factor VEGF, thereby “starving” the tumour (Zhang et al., 2020).
Facts and figures:
- Research has shown that sulforaphane reduces the growth of prostate cancer cells by more than 70% (Ambrosone et al., 2016).
- In patients with colon cancer, regular consumption of sulforaphane was found to reduce tumour volume by 34% (Clarke et al., 2008).
Clinical evidence: Sulforaphane in cancer therapy
Prostate cancer
A clinical study published in the American Journal of Clinical Nutrition showed that men who consumed 60 g of broccoli sprouts daily for 12 weeks had 45% lower levels of PSA, a marker associated with prostate cancer (Ambrosone et al., 2016).
Colon cancer
Sulforaphane has been shown to reduce inflammatory processes that contribute to the development of colon cancer. Patients in the study experienced a decrease in the number of polyps and inflammatory markers (Clarke et al., 2008).
Lung cancer
Smokers who regularly consumed sulforaphane showed up to 50% lower concentrations of carcinogenic substances associated with tobacco smoke. This effect was particularly evident in countries with high smoking rates, such as China (Fahey et al., 2011).
Current and future trends in favour of sulforaphane
1. Personalised medicine
Sulforaphane is increasingly being incorporated into personalised medicine research. New technologies enable precise targeting of treatment using nanoparticle delivery systems that specifically transport sulforaphane to tumour cells, thereby maximising its effectiveness.
2. Combination with immunotherapy and chemotherapy
Ongoing studies are investigating the combination of sulforaphane with traditional cancer treatments such as immunotherapy and chemotherapy. Preliminary results suggest that sulforaphane may enhance the effects of drugs while mitigating the side effects of chemotherapy.
3. New generation food supplements
Sulforaphane is available in nutraceutical form (myrosinase-activated), with an emphasis on its bioavailability. Modern processing technologies enable the creation of more stable and effective forms of sulforaphane.
4. Prevention as part of your lifestyle
Preventive approaches involving regular consumption of broccoli sprouts or dietary supplements are growing in popularity. This trend is also supported by growing awareness of the benefits of functional foods.
Sources used
- Fahey, J. W., et al. (2011).
"Sulforaphane: Translational Research from Laboratory Bench to Clinic."
Cancer Prevention Research, 4(7), 735–743.
DOI: 10.1158/1940-6207.CAPR-10-0324- Ambrosone, C. B., et al. (2016).
"Broccoli and Prostate Cancer Prevention: Results from a Randomised Trial."
American Journal of Clinical Nutrition, 103(3), 724–731.
DOI: 10.3945/ajcn.115.121004- Clarke, J. D., et al. (2008).
"Metabolism and Tissue Distribution of Sulforaphane in Humans."
Carcinogenesis, 29(9), 1775–1783.
DOI: 10.1093/carcin/bgn160- Zhang, Y., et al. (2020).
"Mechanisms of Sulforaphane in Cancer Therapy: An Update."
Journal of Medicinal Chemistry, 63(3), 2031–2052.
DOI: 10.1021/acs.jmedchem.9b00957




